ANNOUNCED ONGOING Drug recall · Reported 21 Oct 2026 · FDA company announcement, classification pending
No Brand Name Compounded veterinary medications recalled
Wedgewood Pharmacy is recalling No Brand Name Compounded veterinary medications, distributed nationwide in the US. The recall was initiated on 21 Oct 2026 and is listed as ongoing.
Recall details
- Recall number
- FDA-PR-700a68a8ef73
- Recalling firm
- Wedgewood Pharmacy
- Brand
- No Brand Name
- Classification
- Pending
- Status
- Ongoing
- Recall initiated
- 21 Oct 2026
- Reported
- 21 Oct 2026
- Reason category
- Potency & Assay
- Drug class
- Compounded Drugs
Timeline
| 21 Oct 2026 | Recall initiated by company | |
| 21 Oct 2026 | Published in enforcement report | +0 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Potential Potency Issues. SWEDESBORO, N.J., (October 21, 2026) - Wedgewood Pharmacy LLC ("Wedgewood") is recalling certain compounded veterinary medications within expiry at the provider/customer level due to inconsistencies in the reliability of certain analytical testing data generated by their laboratory, potentially resulting in subpotent and/or superpotent products. The affected products were shipped between February 18, 2026 and October 6, 2026 to veterinary practices, pharmacies, and other customers nationwide in the U.S. The issue was discovered through Wedgewood’s own quality processes. A complete list of affected products (including powders, pastes, oral suspensions, injectables, ophthalmic ointments and solutions, ear solutions and suspensions, topical sprays, and gels), lot numbers, and expiration dates are available at www.wedgewood.com/recall-lookup/. The products involved are intended for companion, equine, exotic, zoo, wildlife, and aquatic animals. They are not intended for use in food-producing animals. Hazard Statement: The health risks involved with low potency can include ineffective treatment and the health risks involved with high potency can include toxicity or overdose. To date, Wedgewood has received 98 complaints, of which 7 are serious. Customers should contact their veterinarians if they have medical concerns. For customers: Wedgewood has engaged Sedgwick to support the coordination of this recall. Sedgwick is notifying affected customers via email and mail and is arrangin
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the company
No Brand Name Compounded veterinary medications
Where it was distributed
Nationwide
Questions about this recall
Why was it recalled?
Potential Potency Issues. SWEDESBORO, N.J., (October 21, 2026) - Wedgewood Pharmacy LLC ("Wedgewood") is recalling certain compounded veterinary medications within expiry at the provider/customer level due to inconsistencies in the reliability of certain analytical testing data generated by their laboratory, potentially resulting in subpotent and/or superpotent products. The affected products were shipped between February 18, 2026 and October 6, 2026 to veterinary practices, pharmacies, and other customers nationwide in the U.S. The issue was discovered through Wedgewood’s own quality processes. A complete list of affected products (including powders, pastes, oral suspensions, injectables, ophthalmic ointments and solutions, ear solutions and suspensions, topical sprays, and gels), lot numbers, and expiration dates are available at www.wedgewood.com/recall-lookup/. The products involved are intended for companion, equine, exotic, zoo, wildlife, and aquatic animals. They are not intended for use in food-producing animals. Hazard Statement: The health risks involved with low potency can include ineffective treatment and the health risks involved with high potency can include toxicity or overdose. To date, Wedgewood has received 98 complaints, of which 7 are serious. Customers should contact their veterinarians if they have medical concerns. For customers: Wedgewood has engaged Sedgwick to support the coordination of this recall. Sedgwick is notifying affected customers via email and mail and is arrangin
Where was it sold?
Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does an unclassified recall mean?
The FDA assigns a class once it has assessed the health risk. Until then the recall is listed without one.
Read the official FDA notice · Source record retrieved 21 Oct 2026. This is a company announcement published by the FDA; the FDA has not yet classified the recall. The record is updated when the classification appears in the Enforcement Report. This page reports the record and gives no medical advice.